PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33178215-8	2020	However, even when accounting for this, the presence of high titer NAbs were also associated with higher disease activity during IFNbeta treatment.	nabs	67-71	IFN1@	Homo sapiens	129-136	
33178215-11	2020	Conclusion: High titer NAbs to IFNbeta are associated with higher disease activity, persisting even after IFNbeta discontinuation or switch.	nabs	23-27	IFN1@	Homo sapiens	31-38	
33178215-11	2020	Conclusion: High titer NAbs to IFNbeta are associated with higher disease activity, persisting even after IFNbeta discontinuation or switch.	nabs	23-27	IFN1@	Homo sapiens	106-113	
35508100-2	2022	However, up to 47% of treated patients will develop neutralizing anti-drug antibodies (NAbs) against IFNbeta, which at high titres can inhibit the therapeutic effect of the drug.	nabs	87-91	IFN1@	Homo sapiens	101-108